Biotalys Reports 2025 Results and Strategic Refocus as EVOCA Gains First U.S. State Registration
Biotalys reports a €15.8 million net loss for 2025, announces a strategic refocus on lead biofungicide assets, and secures Florida state registration for EVOCA as its first AGROBODY biocontrol approved by a U.S. state.